Publications

Wellbeing and Human Capital

Muttarak, R., Ghislandi, S.. Demographic Perspectives on Global Health. In: Raviglione, M.C.B., Tediosi, F., Villa, S., Casamitjana, N., Plasència, A. (eds) Global Health Essentials. Sustainable Development Goals Series. Springer, Cham (2023). https://doi.org/10.1007/978-3-031-33851-9_5 

Menta G, Lepinteur A, Clark A, Ghislandi S, D'Ambrosio C. Maternal Genetic risk  for depression and child human capital. Journal of Health Economics. 2023: Vol 87, 102718. DOI (open access): https://doi.org/10.1016/j.jhealeco.2022.102718  

Lutz W, Striessnig E, Dimitrova A, Ghislandi S, Lijadi A, Reiter C, Spitzer S, Yildiz D. Years of Good Life (YoGL): A wellbeing indicator designed to serve research on sustainability. Proceedings of the National Academy of Sciences. 2021. DOI: 10.1073/pnas.1907351118 

Ghislandi S, Sanderson W, Scherbov S. A Simple Measure of Human Development: the Human Life Indicator. Population and Development Review, 2019: Vol 45(1): 219-233

Clark A, D'Ambrosio C, Ghislandi S. Adaptation to Poverty in Long-run Panel Data. Review of Economics and Statistics. 2016; 98(3); 591-600. Paper (subscription required)

Clark A, D'Ambrosio C, Ghislandi S. Poverty Profiles and Well-Being: Panel Evidence from Germany. Research on Economic Inequality. 2015; Vol 23; 1-22

Ghislandi S, Apolone G, Garattini L, Ghislandi I. Is EQ-5D a valid measure of HRQoL in patients with movement disorders? The European Journal of Health Economics, 2002; 3(2): 125-130. Paper (subscription required)

Health Policy and Management

Ghislandi S, Renner AT, Varghese NE: The impact of budget cuts on individual patient health: Causal evidence from hospital closures. Journal of Health Economics. 2025: vol 101. (Open access): 10.1016/j.jhealeco.2025.102975.

Trentini, F., Ciani, O., Vanni, E,  Ghislandi S., Torbica A, Azzolini E, Melegaro A: A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy. Scientific Reports-Nature 13, 12386 (2023). https://doi.org/10.1038/s41598-023-39592-7 

Bosa, I., Castelli, A., Castelli, M., Ciani, O., Compagni, A., Galizzi, M., Garofano M, Ghislandi S,  Giannoni M, Marini G., Vainieri, M: Corona-regionalism? Differences in regional responses to COVID-19 in Italy. Health Policy. 2021: vol  125(9); pp  1179-1187. 

Bosa, I., Castelli, A., Castelli, M., Ciani, O., Compagni, A., Galizzi, M., Garofano M, Ghislandi S,  Giannoni M, Marini G., Vainieri, M: Response to COVID-19: Was Italy (un)prepared? Health Economics, Policy and Law. 2021;  pp 1-13. doi:10.1017/S1744133121000141 

Tarricone R, Listorti E, Tozzi V, Torbica A, Banks H, Ghislandi S, Altini M, Annicchiarico M, Ardizzoni A, Bordon P, Bossi P, Cascinu S, Numico G, Puglisi F, Fasola G. Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy. J Cancer Policy. 2021. doi: 10.1016/j.jcpo.2021.100297.  

Wang Y, Ghislandi S, Torbica: Investigating the geographic disparity in quality of care: the case of hospital readmission after acute myocardial infarction in Italy. European Journal of Health Economics,  2020: vol 21: 1149–1168. https://doi.org/10.1007/s10198-020-01221-9

Veronesi G, Navone N, Novellis P, Dieci E, Toschi L, Velutti L, Solinas M, Vanni E, Alloisio M, Ghislandi S: Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy. Lung Cancer, 2020: vol 143: 73 - 79 , (https://doi.org/10.1016/j.lungcan.2020.03.015 )

Fiestas Navarrete L, Ghislandi S, Stuckler D, Tediosi F. Inequalities in the benefits of national health insurance on financial protection from out-of-pocket payments and access to health services: cross-sectional evidence from Ghana. Health Policy and Planning., 2019:  vol 34(9): 694-705( (https://doi.org/10.1093/heapol/czz093)

Ghislandi S. Muttarak R. Fair choices in universal health coverage in Thailand. The  Lancet, 2016; Vol. 388: 1155-1156

Ghislandi S, Manatchothpong W, Perego V. The impact of Universal Health Coverage on health consumption and risky behaviors: evidence from Thailand. Health Economics, Policy and Law. 2015; 10(3); 251-266  Paper (subscription required)

D’Ambrosio C, Ghislandi S: Health insurance: economic and risk aspects. In: International Encyclopedia of Social and Behavioral Sciences, edited by James Wright, Elsevier. 2015.

Ghislandi S, Crosignani G, Negri E, La Vecchia C, Zocchetti C. Sex and age differences in health expenditure from northern Italy. Epidemiology, Biostatistics and Public Health. 2014; 11(4); 1-8. Paper

Ghislandi S, Torbica A, Boriani G. Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data. BMC Health Services Research. 2013 Mar 15;13:100. Paper

Cappellaro G, Ghislandi S, Anessi-Pessina E. Diffusion of medical technology:  the role of financing. Health Policy. 2011 Apr;100(1):51-9. Paper (subscription required)

Pharmaceutical economics and policy

Jommi C, Listorti E, Villa F, Ghislandi S, Genazzani A, Cangini A, Trotta F. Variables affecting pricing of orphan drugs: the Italian case. Orphanet J Rare Dis. 2021 Oct 19;16(1):439. Paper. 

Curto A, Ghislandi S, Van de Vooren K, Duranti S, Garattini L. Regional tenders on biosimilars in Italy: an empirical analysis of awarded prices. Health Policy. 2014 Jun; 116(2): 182-7. Paper (subscription required)

Ghislandi S, Armeni P, Jommi C. The impact of generic reference pricing in Italy, a decade on. The European Journal of Health Economics. 2013; 14(6): 959-969. Paper (subscription required)

Ghislandi S. Competition and the Reference Pricing Scheme for pharmaceuticals. Journal of Health Economics. 2011 Dec;30(6):1137-49. Paper (subscription required)

Galizzi MM, Ghislandi S, Miraldo M. Effects of reference pricing in pharmaceutical markets: a review. Pharmacoeconomics. 2011 Jan;29(1):17-33. Paper (subscription required)

Garattini L, Ghislandi S. Should we really worry about "launch delays" of new drugs in OECD countries? The European Journal of Health Economics. 2007 Mar;8(1):1-3. Paper (subscription required)

Garattini L, Ghislandi S. Off-patent drugs in Italy. The European Journal of Health Economics. 2006 Mar;7(1):79-83. Paper (subscription required)

Ghislandi S, Krulichova I, Garattini L. Pharmaceutical policy in Italy: towards a structural change? Health Policy. 2005 Apr;72(1):53-63. Paper (subscription required)

Garattini L, Tediosi F, Ghislandi S, Orzella L, Rossi C. How do Italian pharmacoeconomists evaluate indirect costs? Value in Health, 2000; 3(4): 270-276. Paper 

Epidemiology

Amerio A, Stival C, Lugo A, et al. COVID-19 pandemic impact on mental health in a large representative sample of older adults from the Lombardy region, Italy. Journal of Affective Disorders 2023; 325: 282-288. https://doi.org/10.1016/j.jad.2023.01.006 

Bosetti, C., Rognoni, M., Ciampichini, R. et al. A real world analysis of COVID-19 impact on hospitalizations in older adults with chronic conditions from an Italian region. Scientific  Reports-Nature, 2022: vol.  12, 13704 . https://www.nature.com/articles/s41598-022-17941-2 

Ghislandi S, Muttarak R, Sauerberg M, Scotti B: Human costs of the first wave of the COVID-19 pandemic in the major epicentres in Italy. In: Vienna Yearbook of Population Research 2022, 2021 pp 1-31. Paper. 

Odone, A., Lugo, A., Amerio, A. et al.: Covid-19 lockdown impact on lifestyle habits of Italian adults. Acta Biomedica. 2020, 91. https://doi.org/10.23750/abm.v91i9-S.10122 

Varghese NE, Lugo A, Ghislandi S, Colombo P, Pacifici R, Gallus S: Sleep dissatisfaction and insufficient sleep duration in the Italian population. Scientific Reports-Nature, 2020:  vol  10: 17943  (https://doi.org/10.1038/s41598-020-72612-4)

Barazzetta M, Ghislandi S. Family income and material deprivation: do they matter for sleep quality and quantity in early life? Evidence from a longitudinal study. Sleep, 2017; Vol 40. 

Torbica A, Ghislandi S, Maggioni A. The economic crisis and acute myocardial infarction: new evidence using hospital-level data. PLOS_One.  10(11): November 17. e0142810. doi:10.1371/journal.pone.0142810. Paper

Gallus S, Ghislandi S, Muttarak R. Effects of the economic crisis on smoking prevalence and number of smokers in the USA. Tobacco Control. 2015; 24; 82-88. Paper (subscription required)

Gallus S, Lugo A, Ghislandi S, La Vecchia C, Gilmore A. Roll-your-own cigarettes: use, weight and implication for fiscal policies. European Journal of Cancer Prevention. 2014; 23(3):186-192.  Paper (subscription required)

Gallus S, Tramacere I, Pacifici R, Zuccaro P, Colombo P, Ghislandi S, LaVecchia C. Smoking in Italy 2008-2009: a rise in prevalence related to the economic crisis? Preventive Medicine. 2011 Feb;52(2):182-3. Paper (subscription required)

Miscellanea

Devillanova C, Ghislandi S. Labour tax reforms and labour market outcomes in Europe. Rivista di Diritto Finanziario e Scienza delle Finanze, 2011; (3): 380-393

Working paper, preprints and under revision

Ghislandi S, Scotti B: Lifespan inequalities among the over 50s: evidence from administrative data in Italy. VisitINPS papers, n.55, 2022. https://www.inps.it/docallegatiNP/Mig/InpsComunica/WorkInps_Papers/55_Ghislandi_Scotti.pdf 

West, A., Czypionka, T., Steffen, M., Ettelt, S., Ghislandi, S. and Mateus, C. (2020) Reporting of COVID-19 deaths in Austria, France, Germany, Italy, Portugal and the UK, Social Policy Working Paper 10-20, London: LSE Department of Social Policy. 

Ghislandi S, Muttarak R, Sauerberg M, Scotti B: News from the Front: Estimation of excess mortality and life expectancy in the major epicenters of COVID-19 in Italy. (Preprint)

Ghislandi S, Muttarak R , & Shaikh M (2020). Empowering girls, delaying marriage: Exploring the role of marital age and education on domestic violence in India. IIASA Working Paper. Laxenburg, Austria: WP-20-002 

Ghislandi S, Kuhn M. Asymmetric Information in the Access to Markets. Department of Economics, WU University, WP  219, 2016. 

Ghislandi S. Product hopping and pre-emptive cannibalization in pharmaceuticals. ECONPUBBLICA, Bocconi University, WP 169, 2012. Paper

Galizzi MM, Ghislandi S, Miraldo M. The economic effects of Reference Pricing for pharmaceuticals. Report prepared for the Finnish Ministry of Social Affairs and Health, 2009. Report

Farlow A, Ghislandi S. Modelling and methodology in: The Malaria product pipeline. Pharmaceutical R&D Policy Project (edt Moran M, Guzman J, Ropars AL, Jorgensen M, McDonald A, Potter S, Selassie HH) George Institute for International Health, 2008, Sidney. Report